BDBM50200914 CHEMBL3931239

SMILES: C[C@@H]1CN(Cc2ccc(o2)C(F)(F)F)c2ccccc2[C@H](C)N1C(=O)Nc1cccnc1

InChI Key: InChIKey=KOKBUUOJONICIJ-CVEARBPZSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50200914   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Voltage-dependent T-type calcium channel subunit alpha-1H (Homo sapiens (Human))	BDBM50200914 (CHEMBL3931239) Show SMILES C[C@@H]1CN(Cc2ccc(o2)C(F)(F)F)c2ccccc2[C@H](C)N1C(=O)Nc1cccnc1 |r| Show InChI InChI=1S/C23H23F3N4O2/c1-15-13-29(14-18-9-10-21(32-18)23(24,25)26)20-8-4-3-7-19(20)16(2)30(15)22(31)28-17-6-5-11-27-12-17/h3-12,15-16H,13-14H2,1-2H3,(H,28,31)/t15-,16+/m1/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	14	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.2 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair
Voltage-gated T-type calcium channel (Homo sapiens (Human))	BDBM50200914 (CHEMBL3931239) Show SMILES C[C@@H]1CN(Cc2ccc(o2)C(F)(F)F)c2ccccc2[C@H](C)N1C(=O)Nc1cccnc1 |r| Show InChI InChI=1S/C23H23F3N4O2/c1-15-13-29(14-18-9-10-21(32-18)23(24,25)26)20-8-4-3-7-19(20)16(2)30(15)22(31)28-17-6-5-11-27-12-17/h3-12,15-16H,13-14H2,1-2H3,(H,28,31)/t15-,16+/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair
Voltage-gated T-type calcium channel (Homo sapiens (Human))	BDBM50200914 (CHEMBL3931239) Show SMILES C[C@@H]1CN(Cc2ccc(o2)C(F)(F)F)c2ccccc2[C@H](C)N1C(=O)Nc1cccnc1 |r| Show InChI InChI=1S/C23H23F3N4O2/c1-15-13-29(14-18-9-10-21(32-18)23(24,25)26)20-8-4-3-7-19(20)16(2)30(15)22(31)28-17-6-5-11-27-12-17/h3-12,15-16H,13-14H2,1-2H3,(H,28,31)/t15-,16+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.3 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair